Heska Corp buy melinda
Start price
22.09.17
/
50%
€80.77
Target price
05.10.17
€85.69
Performance (%)
7.92%
End price
05.10.17
€87.17
Summary
This prediction ended on 05.10.17 with a price of €87.17. The BUY prediction by melinda finished with a performance of 7.92%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Heska Corp | - | - | - | - |
| iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
| iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
| iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
| iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by melinda for this prediction
In the thread Heska Corp diskutieren
SecteurEquipement, medizinische Versorgung und Verteilung
Heska Corp. engagiert sich in der Forschung, Entwicklung und Herstellung von Tierarzneimitteln. Das Unternehmen gliedert sich in zwei Segmente: Kern Companion Animal Health und anderen Impfstoffen, Arzneimitteln und Produkten. Die Core Companion Animal Health Segment bietet Instrumente Screening Blut, Digital Imaging ..